What is ClindaMed™?
ClindaMed™ Oral Drops is a palatable formulation intended for oral administration. Each mL of ClindaMed™ Oral Drops liquid contains clindamycin hydrochloride equivalent to 25 mg clindamycin; and ethyl alcohol, 8.64%.
Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Indications
ClindaMed™ Oral Drops (for use in dogs and cats) are indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below:
Dogs
- Skin infections (wounds and abscesses)
due to coagulase positive staphylococci (Staphylococcus aureus or Staphylococcus intermedius). - Deep wounds and abscesses
due to Bacteroides fragilis, Prevotella melaninogenicus, Fusobacterium necrophorum and Clostridium perfringens. - Osteomyelitis
due to Staphylococcus aureus, Bacteroides fragilis, Prevotella melaninogenicus, Fusobacterium necrophorum and Clostridium perfringens
Cats
- Skin infections (wounds and abscesses)
due to Staphylococcus aureus, Staphylococcus intermedius, Streptococcus spp - Deep wounds and abscesses
due to Clostridium perfringens and Bacteroides fragilis - Dental infections
due to Staphylococcus aureus, Staphylococcus intermedius, Streptococcus spp., Clostridium perfringens and Bacteroides fragilis
Benefits
- Highly effective
- Multiple indications for both dogs and cats
- Palatable
- Generally well tolerated by the animal
- Ready to use
- Single daily dose in cats
- No refrigeration required
- Dropper included for accurate, safe administration
Additional Safety Information
- Contraindicated in animals with a history of hypersensitivity to preparations containing clindamycin or lincomycin.
- Because of potential adverse gastrointestinal effects, do not administer to rabbits, hamsters, guinea pigs, horses, chinchillas or ruminating animals.
- Patients with severe renal disease and/or severe hepatic disease accompanied by severe metabolic aberrations should be dosed with caution.
- Clindamycin hydrochloride has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents. Use with caution in animals receiving such agents.
- During prolonged therapy of one month or greater, periodic liver and kidney function tests and blood counts should be performed.
- Safety in gestating bitches and queens or breeding male dogs and cats has not been established.
Pack Size
| List No. | Pack Size | Case Size |
|---|---|---|
| 1CLI005 | 20 mL | 72 (6 x 12) |